\
&
Contact us
Starts in 1 week from now
LocationOostende
The European Partnership for Personalised Medicine (EP PerMed) will host the first edition of a Hackathon in Oostende.
The Hackathon will bring together interdisciplinary teams of researchers, innovators, engineers and clinicians to address relevant challenges in personalised medicine, and will explore novel uses and approaches of non-invasive biomarkers. EP PerMed aims to welcome students, researchers, innovators, engineers, clinicians, and entrepreneurs. Participants will focus on the ideation of solutions that improve patient outcomes and experiences. In addition, the event will provide a platform for participants to network and build meaningful partnerships.
Registration is free of charge and open to anyone residing or domiciled in an EU Member State or a Horizon Europe associated country. Note that registrations and team formations close on 8 February.
More information and registration on the Hackaton event page and on the dedicated EP PerMed webpage.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
If you’ve never heard of Limecraft, you’re clearly not working in the media sector. Their SaaS platform provides integrated workflows for media management, scripted and unscripted TV, and subtitling and localisation. It is used by leading broadcasting companies – such as BBC, VRT, NPO… – and production firms of which De Mensen or Hotel Hungaria might ring a bell (at least if you are Belgian).
NCP Flanders went to Ghent to interview Maarten Verwaest, CEO and cofounder, about how he sees Horizon 2020. Limecraft is a partner in the MeMAD project, which is a collaborative RIA project submitted to an ICT call topic.